Nationwide survey of patients in Japan with Bickerstaff brainstem encephalitis: Epidemiological and clinical characteristics

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 12, 2012, Pages 1210-1215

  Koga, Michiaki ^a   Kusunoki, Susumu ^b   Kaida, Kenichi ^c   Uehara, Ritei ^d   Nakamura, Yosikazu ^d   Kohriyama, Tatsuo ^e   Kanda, Takashi ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e HIROSHIMA CITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; GANGLIOSIDE GQ 1B ANTIBODY; IMMUNOGLOBULIN; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; ATAXIA; BICKERSTAFF BRAINSTEM ENCEPHALITIS; CHILD; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; ENCEPHALITIS; EXTERNAL OPHTHALMOPLEGIA; FEMALE; HUMAN; INFANT; INFECTION; JAPAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX; PATHOGENESIS; PLEOCYTOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; SENSORY DYSFUNCTION; TENDON REFLEX;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN STEM; CHILD; CHILD, PRESCHOOL; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS; FEMALE; GANGLIOSIDES; HEALTH SURVEYS; HUMANS; JAPAN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PHYSICIANS, PRIMARY CARE; QUESTIONNAIRES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84869239666     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-303060     Document Type: Article

References (26)

1. Al-Din AN, Anderson M, Bickerstaff ER, et al. Brainstem encephalitis and the syndrome of Miller Fisher: a clinical study. Brain 1982;105:481-95. (Pubitemid 12004279)
2. Yaqub BA, al-Deeb SM, Daif AK, et al. Bickerstaff brainstem encephalitis. A grave non-demyelinating disease with benign prognosis. J Neurol Sci 1990;96:29-40. (Pubitemid 20137627)
3. Odaka M, Yuki N, Yamada M, et al. Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome. Brain 2003;126:2279-90. (Pubitemid 37432371)
4. Bickerstaff ER, Cloake PC. Mesencephalitis and rhombencephalitis. BMJ 1951;2:77-81.
5. Bickerstaff ER. Brain-stem encephalitis; further observations on a grave syndrome with benign prognosis. BMJ 1957;1:1384-7.
6. Overell JR, Hsieh ST, Odaka M, et al. Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders. Cochrane Database Syst Rev 2009;1:CD004761.
7. Yuki N, Sato S, Tsuji S, et al. An immunologic abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome. J Neuroimmunol 1993;118:83-7. (Pubitemid 23269971)
8. Ogawara K, Kuwabara S, Yuki N. Fisher syndrome or Bickerstaff brainstem encephalitis? Anti-GQ1b IgG antibody syndrome involving both the peripheral and central nervous systems. Muscle Nerve 2002;26:845-9. (Pubitemid 35424439)
9. Ito M, Kuwabara S, Odaka M, et al. Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol 2008;255:674-82.
10. Chiba A, Kusunoki S, Obata H, et al. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993;43:1911-17. (Pubitemid 23318855)
11. Willison HJ, Veitch J. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J Neuroimmunol 1994;50:159-65.
12. Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry 2001;70:50-5. (Pubitemid 32096120)
13. Yuki N. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann Neurol 1996;39:668-72.
14. Nakamura Y, Matsumoto T, Tamakoshi A, et al. Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan. J Epidemiol 2000;10:29-33.
15. Kuriyama S, Kusaka Y, Fujimura M, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 2008;39:42-7.
16. Sakushima K, Tsuboi S, Yabe I, et al. Nationwide survey on the epidemiology of syringomyelia in Japan. J Neurol Sci 2012;313:147-52.
17. Saito T, Arimura K, Osame M. Nationwide survey of Guillain-Barré syndrome in Japan: therapeutic preliminary report. Prog Med 1999;19:2369-74.
18. Yuki N. Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher-Bickerstaff syndrome). J Neuroimmunol 2009;215:1-9.
19. Shuaib A, Becker WJ. Variants of Guillain-Barré syndrome: Miller Fisher syndrome, facial diplegia and multiple cranial nerve palsies. Can J Neurol Sci 1987;14:611-16. (Pubitemid 18001908)
20. Problems in Neurology. Guillain-Barré syndrome variants in Emilia-Romagna, Italy, 1992-3: incidence, clinical features, and prognosis. J Neurol Neurosurg Psychiatry 1998;65:218-24.
21. Govoni V, Granieri E, Tola MR, et al. The frequency of clinical variants of Guillain-Barré syndrome in Ferrara, Italy. J Neurol 1999;246:1010-14.
22. Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré Syndrome. Philadelphia, PA: FA Davis Company, 1991:106-21.
23. Mori M, Kuwabara S, Fukutake T, et al. Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001;56:1104-6. (Pubitemid 32336323)
24. Lyu RK, Tang LM, Cheng SY, et al. Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients. J Neurol Neurosurg Psychiatry 1997;63:494-500.
25. Yuan CL, Wang YJ, Tsai CP. Miller Fisher syndrome: a hospital-based retrospective study. Eur Neurol 2000;44:79-85.
26. Koga M, Gilbert M, Takahashi M, et al. GQ1b-seronegative Fisher syndrome: clinical features and new serological markers. J Neurol 2012;259:1366-74.